You are here
- Home
- Therapy Areas
- Respiratory/Inflammation
New Breath Actuated MDI Symbicort Compared to Symbicort pMDI and Budesonide pMDI for 12 Weeks Twice a Day
- Disease
- asthma
- Drug Name
- Symbicort
- Generic Name
- budesonide/formoterol
- Sponsor
- AstraZeneca
- Drug Status
- Approved Medicine
- Phase
- III
- Start Date
- Nov 28, 2011
- Study Name
- BAI
- Study Id
- D589OC00003
- ClinicalTrials.gov ID
- NCT01360021
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
